ROOEY Imaging Technology Corp. Deepens Development of Its AI-Driven Cancer Imaging System

VANCOUVER, British Columbia - Nov. 18, 2025 - PRLog -- ROOEY Imaging Technology Corp. is advancing the development of its AI-enhanced diagnostic platform, building on the foundational capabilities outlined in its initial announcement. Current work focuses on refining automated lesion detection and malignancy prediction models, and on standardizing workflow tools to address rising imaging volumes and differences in human interpretation. These improvements are designed to support a wide range of healthcare institutions, from major cancer centers to remote clinics with limited diagnostic resources.

Progress is also underway on integrated collaboration features, including real-time telemedicine support and augmented reality–based image annotation. These capabilities aim to strengthen communication between radiologists, oncologists, and multidisciplinary teams, reducing diagnostic delays and creating more consistent clinical pathways. The platform's flexible SaaS model continues to expand, offering subscription and pay-per-use options tailored to diverse institutional needs.

Additional development targets automated reporting, predictive analytics, and data standardization to minimize manual workload and streamline patient pathways. As ROOEY Imaging Technology Corp. advances its platform, the business remains focused on improving access to diagnostic expertise, enhancing infrastructure that benefits both urban and underserved regions, and supporting broader improvements in cancer care delivery.

About ROOEY Imaging Technology Corp.: ROOEY is a forward-thinking healthcare technology company specializing in advancing the detection and diagnosis of cancer through sophisticated AI-driven solutions. Learn more at https://rooeytech.com/.